前列腺动脉栓塞研究议程的制定:介入放射学会共识专家组的总结
介入放射学会基金会研究共识专家组就前列腺动脉栓塞(PAE)研究议程进行讨论,认为PAE治疗下尿路症状安全有效,但美国缺乏随机对照试验,导致未能纳入美国泌尿学会指南推荐。专家组未能就三种研究设计达成共识,建议建立非企业资助的登记研究以获取真实世界数据。
要点
- PAE治疗下尿路症状已被证明安全有效,可减轻症状和缩小前列腺体积。
- 美国缺乏PAE随机对照试验,导致其未纳入美国泌尿学会指南推荐。
- 专家组未就三种研究设计达成共识,建议建立非企业资助的登记研究。
核心结论
- 专家组未能就PAE研究设计达成共识,因对三种设计意见分歧,计划进一步会议从中选择。
研究设计与样本
- 介入放射学会基金会资助的研究共识专家组会议,成员包括介入放射科医生、泌尿科医生、基金会领导层和行业代表,目的是讨论现有数据的不足和美国试验的研究设计。
诊断标准与关键数值
- 纳入美国泌尿学会指南需要Level 1数据;专家组未就三种研究设计达成共识:PAE与假手术随机对照试验(假手术组交叉)、PAE与简单前列腺切除术随机对照试验、PAE与钬激光前列腺剜除术/铥激光前列腺剜除术随机对照试验。
临床应用与阅片要点
- 专家组推荐建立非企业资助的登记研究以获取真实世界数据。
局限性
- 专家组因对三种研究设计均有顾虑而未达成共识。
- 需要进一步会议以从中选择研究设计。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: To summarize the Society of Interventional Radiology Foundation's Research Consensus Panel development of a research agenda on prostate artery embolization (PAE).
MATERIALS AND METHODS: PAE for the treatment of lower urinary tract symptoms has been shown to be safe and effective in decreasing symptoms and prostate size. Lack of randomized controlled trials (RCTs) on PAE in the United States has prevented inclusion in American Urologic Association guideline recommendations for treatment of lower urinary tract symptoms resulting from benign prostatic hyperplasia. Recognizing the need for well-designed trials, the SIR Foundation funded a Research Consensus Panel to prioritize a research agenda. The panel included interventional radiologists, urologists, SIR Foundation leadership, and industry representatives. The goal of the meeting was to discuss weaknesses with current data and study design for development of US trials to report long-term outcomes data.
RESULTS: Final consensus on a research design could not be made because the group was split on 3 research designs: (i) RCT of PAE versus sham with crossover of the sham group. (ii) RCT of PAE versus simple prostatectomy. (iii) RCT of PAE versus holmium laser enucleation of the prostate/thulium laser enucleation of the prostate. The panel recommended a nonindustry-funded registry to obtain real-world data.
CONCLUSIONS: Level 1 data are required to be included in the American Urologic Association guidelines for treatment of benign prostatic hyperplasia. Because of concerns with all 3 study designs, the panel did not reach a consensus. Further meetings are planned with the panel to select among these research designs.
引用
- Davis C, Golzarian J, White S, et al. Development of Research Agenda in Prostate Artery Embolization: Summary of Society of Interventional Radiology Consensus Panel. J Vasc Interv Radiol. 2019. PMID: 31771895. doi:10.1016/j.jvir.2019.09.019
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。